共 151 条
[1]
Van Cutsem E(2016)Gastric cancer Lancet 388 2654-2664
[2]
Sagaert X(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
[3]
Topal B(2009)Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer Br J Surg 96 1015-1022
[4]
Haustermans K(2013)Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer Cancer Chemother Pharmacol 71 1309-1314
[5]
Prenen H(2014)Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer Cancer Chemother Pharmacol 73 281-285
[6]
Cunningham D(2014)Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer Ann Surg Oncol 21 2340-2346
[7]
Allum WH(2014)Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis Br J Surg 101 653-660
[8]
Stenning SP(2018)Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications Gastric Cancer 21 703-709
[9]
Thompson JN(2009)Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer World J Surg 33 1240-1246
[10]
Van de Velde CJ(2013)Impact of intraoperative blood loss on survival after curative resection for gastric cancer World J Gastroenterol 19 5542-5550